Managing NAFLD and NASH: Applying the AACE Guideline to Your Practice
CME Credits:
MOC Credits:


Managing NAFLD and NASH

<p>With the goal of reducing the dramatic gap between how nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are currently screened, diagnosed, and managed, AACE released at its 2022 Annual Meeting in May, the new AACE Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings co-sponsored by the American Association for Study of Liver Diseases (AASLD).</p>

<p>To ensure that endocrinologists, gastroenterologists, hepatologists, primary care physicians, and all other HCPs, who are in a position to identify and care for patients at risk of developing NAFLD and/or NASH, are familiar with this guideline, clinicians require education about how to implement current AACE recommendations in their practice and thus identify patients early to prevent the development of liver fibrosis progression to cirrhosis, and comorbidities.&nbsp;</p>

CME/MOC Credits

Starts February 2023 | Expires February 2024

Learning Objectives 

Upon successful completion of the program, participants should be better able to: 

  • Identify the diagnosis and management of NAFLD and NASH as the hepatic manifestation of the metabolic syndrome.
  • Describe noninvasive tests currently used and in development for identifying patients with NAFLD and NASH, and those at high risk for clinically significant liver fibrosis.
  • Review the efficacy of various treatments for NAFLD and NASH, including pharmacotherapy such as GLP-1 RA.
  • Apply the latest management recommendations in clinical practice from the AACE Clinical Practice Guideline on NAFLD and NASH.

Listen to Carolyn share her father's NAFLD and NASH experience.

Read Clinical Practice Guideline

Planners and Faculty

Planners and Faculty

Kenneth Cusi, MD, FACP, FACE
Division of Endocrinology, Diabetes and Metabolism, University of Florida
Gainesville, Florida

Romina Lomonaco, MD
Assistant Professor
Division of Endocrinology, Diabetes and Metabolism, University of Florida
Gainesville, Florida

Zobair M. Younossi MD, MPH, FACP, FACG, AGAF, FAASLD
President, Inova Medicine Services
Chairman, Clinical Research
Inova Health System
Professor and Chairman, Department of Medicine, Inova Fairfax Medical Campus

Sangeeta Kashyap, MD
Professor of Medicine Cleveland Clinic Lerner College of Medicine
Associate Program Director for Endocrinology
Diabetes and Metabolism Fellowship
Associate Editor of Journal of Clinical Endocrinology and Metabolism


Target Audience

The target audience for this activity is intended for HCPs involved in treating patients with NASH/NAFLD, including endocrinologists, gastroenterologists, hepatologists, primary care physicians, and advanced practice professionals (nurse practitioners, physician assistants, etc.

Accreditation and Designation Statements

Physicians and Physician Assistants

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.


American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 3 contact hours.